2 magnificent dividend stocks for recurrent income!

Identifying dividend stocks for passive income isn’t easy. There are many things to consider but our writer reckons she’s found two great options.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young mixed-race woman jumping for joy in a park with confetti falling around her

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Two dividend stocks I think would be ideal for helping me build a second income stream are GSK (LSE: GSK) and Anglo American (LSE: AAL). Here’s why!

Essential healthcare

GSK is one of the biggest pharmaceutical businesses in the world with a mammoth footprint and a plethora of well-known products used everyday by millions of people.

Due to macroeconomic and geopolitical volatility, GSK shares have meandered up and down in the past 12 months. However, they’re up 10% from 1,414p at this time last year, to current levels of 1,567p.

A big reason GSK is a great passive income stock for me is its defensive nature. Healthcare is essential for all no matter the economic outlook. This can span day-to-day drugs to more complex treatments for illnesses. This defensive ability allows the business to record stable earnings and reward investors.

Speaking of returns, a dividend yield of 4% is pretty attractive and it looks well covered by earnings, which is important. However, it’s worth remembering that dividends are never guaranteed. GSK also shares look excellent value for money right now on a price-to-earnings ratio of 10.

From a risk perspective, when pharma firms experience product issues, sentiment, performance, and returns can be impacted. GSK has had this before. It has faced lawsuits due to its discontinued Zantac heartburn drug.

Overall I’d be willing to buy GSK shares for my holdings the next time I have some investable cash.

Mining giant

Anglo American is one of the biggest mining businesses in the world and mines commodities including iron ore, copper, and nickel.

To say 2023 was a difficult year for Anglo American shares would be an understatement. The shares have fallen 47% over a 12-month period from 3,493p at this time last year to current levels of 1,849p.

Commodities are cyclical, which is a big risk. Production issues can hurt performance, returns, and sentiment. This has hurt Anglo in recent times as it has downgraded production forecasts.

However, I reckon the long-term outlook is favourable. Major initiatives in the future that will require huge quantities of the commodities that Anglo mines will boost the business, in my opinion. These include decarbonisation and infrastructure building. This is in line with the world’s growing population. For example, copper is essential in building infrastructure, as well as electricity grids for new and growing cities. This increased demand should help boost performance and returns.

Speaking of returns, an enticing dividend yield of 5.5% has been pushed up by the falling share price. However, the business has an excellent track record of investor returns and an attractive policy of returning 40% of underlying earnings to investors. I’m conscious that past performance is not a guarantee of the future and policies can change, as dividends are paid at the discretion of the business.

Anglo is another stock I’d be willing to buy when I next have some spare cash to invest. A mixed 2023 hasn’t fazed me. In fact, it’s thrown up an opportunity to buy cheaper shares now on a P/E ratio of 10, ahead of any rally and bull run.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

At 69p, is the Vodafone share price the biggest bargain on the FTSE 100?

On paper, the Vodafone share price looks like an attractive investment opportunity. But is that really the case? This Fool…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

1 dividend superstar that could electrify a passive income portfolio!

This FTSE 100 stock has strong defensive qualities and an excellent dividend history. Here's why passive income investors should consider…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Up 33% in a year! But I think this top FTSE growth stock can keep on climbing

Harvey Jones is kicking himself for failing to buy this profitable FTSE 100 growth stock. Now he can't see any…

Read more »

Investing Articles

I’d buy 10,257 shares in this UK REIT and reinvest the dividends to target a £6,857 second income

With a 7% dividend yield, right now might be an unusually good opportunity to start earning a second income by…

Read more »

View of Tower Bridge in Autumn
Investing Articles

I’m buying UK shares while they’re still dirt cheap!

UK shares look like great value for money and this Fool plans to make the most of it. Here he…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

£12,000 in savings? Here’s how I’d aim to turn that into a £23,920 annual passive income!

This Fool breaks down how he'd target thousands in passive income every year by investing in stocks with high dividend…

Read more »

Investing Articles

If I’d invested £1,000 before the IAG share price collapsed, here’s what I’d have now

The IAG share price has been resurgent in recent months with a near-index-topping 17.9% growth since the beginning of the…

Read more »

Investing Articles

2 reliable growth stocks I’d consider for a new Stocks and Shares ISA in 2024

There's still lots of time to pack that Stocks and Shares ISA with all the best mid-cap UK growth stocks…

Read more »